CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de CARLOS](/img/nophoto.png)
![Foto de Hospital Universitario La Paz](/img/noimage_org.png)
Hospital Universitario La Paz
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario La Paz (16)
2024
2023
-
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study
BMJ open, Vol. 13, Núm. 7, pp. e071371
-
Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14
2022
-
Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy
Immunology, Vol. 165, Núm. 2, pp. 234-249
-
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC
Transplantation and Cellular Therapy, Vol. 28, Núm. 4, pp. 204.e1-204.e10
2021
-
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Trials, Vol. 22, Núm. 1
-
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
EClinicalMedicine, Vol. 39
-
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
Frontiers in Cell and Developmental Biology, Vol. 9
2020
-
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Experimental Hematology and Oncology, Vol. 9, Núm. 1
2014
-
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
Haematologica, Vol. 99, Núm. 10, pp. 1632-1637
2012
-
Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen
Bone Marrow Transplantation, Vol. 47, Núm. 10, pp. 1287-1293
2001
-
Allogeneic transplantation of CD34+ -selected cells from peripheral blood in patients with myeloid malignancies in early phase: A case control comparison with unmodified peripheral blood tranplantation
Bone Marrow Transplantation, Vol. 28, Núm. 4, pp. 349-354
-
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies
British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550
1998
-
Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish Registry
Bone Marrow Transplantation, Vol. 21, Núm. 2, pp. 133-140
-
Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study
Bone Marrow Transplantation, Vol. 22, Núm. 12, pp. 1129-1135
1996
-
Allogeneic peripheral blood progenitor cell transplantation: Analysis of short-term engraftment and acute GVHD incidence in 33 cases
Bone Marrow Transplantation, Vol. 18, Núm. 1, pp. 35-40